2026-01-19 - Analysis Report
# Comprehensive Report on Dollar Tree (DLTR)

## Company Overview
Dollar Tree is a global discount retailer.

## Return Rate Comparison

| Ticker | Cumulative Return (%) |
| --- | --- |
| DLTR (review stock) | 39.58% |
| VOO (comparison stock) | 82.54% |

### Divergence Analysis

- Max: N/A
- Min: N/A
- Current: N/A (difference between VOO and DLTR return rates)
- Relative Divergence: N/A (current position in past data)

### Implication
The review stock (DLTR) has lower cumulative return compared to the comparison stock (VOO).

## Alpha and Beta Analysis

```markdown
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 8.0% | 15.1% | 7.0% | 0.8 | 18.4B |
| 2017-2019  | 28.0% | 15.1% | 19.0% | 0.7 | 19.2B |
| 2018-2020  | 9.0% | 21.1% | -12.0% | 0.8 | 22.0B |
| 2019-2021  | 36.0% | 21.1% | -1.0% | 0.8 | 28.7B |
| 2020-2022  | 34.0% | 21.1% | 24.0% | 0.8 | 28.9B |
| 2021-2023  | 68.0% | 18.7% | 51.0% | 0.8 | 29.0B |
| 2022-2024  | -59.0% | 56.0% | -85.0% | 0.7 | 15.3B |
| 2023-2025  | -37.0% | 56.0% | -86.0% | 0.6 | 25.1B |
```

## Recent Stock Price Fluctuations

- Close: $139.95
- Last-market: $139.95 (close)
- Last-market price change: -0.89
- 5-day SMA: $139.21
- 20-day SMA: $129.77
- 60-day SMA: $115.98

## Indicator Analysis

- Market Risk Indicator (MRI): 0.80 (High Investment Recommended)
- RSI: 81.97
- PPO: 0.43
- Hybrid Signal: Buy (Cash 21%)
- Risk Level: Medium (MRI 0.80)
- Recent relative divergence change: 0.0 (flat)
- 7-day Rank change: 0 (flat)
- 7-day Dynamic Expected Return change: 0.0 (flat)

**Fluctuation issue**
The sharp decline of $-0.89 indicates a fluctuation issue.

## Analyst Opinions

* Analyst Consensus:
  - Key: Hold
  - Mean (1=StrongBuy~5=Sell): 2.74 (~Hold)
  - Opinions: 23
  - Target Price (avg/high/low): 123.61 / 165.00 / 75.00

## Recent Earnings Analysis

| Date | EPS | Revenue |
| ---:|---:|---:|
| 2025-12-03 | 1.2 | 4.75 B$ |
| 2025-09-03 | 0.91 | 4.57 B$ |
| 2025-06-04 | 1.61 | 4.64 B$ |
| 2025-03-26 | -17.18 | 5.00 B$ |
| 2024-12-04 | 1.09 | 4.34 B$ |

## Revenue and Profitability Analysis

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-10-31 | $4.75B | 35.89% |
| 2025-07-31 | $4.57B | 34.43% |
| 2025-04-30 | $4.64B | 35.62% |
| 2025-01-31 | $-5.00B | 12.48% |
| 2024-10-31 | $4.34B | 35.41% |

## Capital and Profitability Analysis

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-10-31 | $3.46B | 7.06% |
| 2025-07-31 | $3.61B | 5.23% |
| 2025-04-30 | $3.90B | 8.79% |
| 2025-01-31 | $3.98B | -92.92% |
| 2024-10-31 | $7.64B | 3.06% |

## Comprehensive Analysis

Review stock (DLTR) has a relatively lower cumulative return and a different performance in Alpha and Beta analysis. Market risk indicator suggests a high investment recommendation, while RSI and PPO indicators suggest a fluctuation issue.

Recent price fluctuations show a sharp decline, and recent relative divergence change is flat. Analyst opinions suggest a hold strategy.

Revenue and profitability analysis show varying results. Capital and profitability analysis also show varying results.

Recent news and earnings analysis should be considered in the investment decision-making process.

Investors are advised to consider multiple factors before making an investment decision.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.